INmune Bio Inc (INMB)
11.62
-0.22
(-1.86%)
USD |
NASDAQ |
May 01, 16:00
11.62
0.00 (0.00%)
After-Hours: 16:55
INmune Bio Max Drawdown (5Y): 80.32% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 80.32% |
| March 31, 2024 | 80.32% |
| February 29, 2024 | 80.32% |
| January 31, 2024 | 80.32% |
| December 31, 2023 | 80.32% |
| November 30, 2023 | 80.32% |
| October 31, 2023 | 80.32% |
| September 30, 2023 | 80.32% |
| August 31, 2023 | 80.32% |
| July 31, 2023 | 80.32% |
| June 30, 2023 | 80.32% |
| May 31, 2023 | 80.32% |
| April 30, 2023 | 80.32% |
| March 31, 2023 | 80.32% |
| February 28, 2023 | 80.32% |
| January 31, 2023 | 80.32% |
| December 31, 2022 | 80.32% |
| November 30, 2022 | 80.32% |
| October 31, 2022 | 80.32% |
| September 30, 2022 | 80.32% |
| August 31, 2022 | 80.32% |
| July 31, 2022 | 80.32% |
| June 30, 2022 | 80.32% |
| May 31, 2022 | 80.32% |
| April 30, 2022 | 79.91% |
| Date | Value |
|---|---|
| March 31, 2022 | 79.91% |
| February 28, 2022 | 79.91% |
| January 31, 2022 | 79.91% |
| December 31, 2021 | 79.91% |
| November 30, 2021 | 79.91% |
| October 31, 2021 | 79.91% |
| September 30, 2021 | 79.91% |
| August 31, 2021 | 79.91% |
| July 31, 2021 | 79.91% |
| June 30, 2021 | 79.91% |
| May 31, 2021 | 79.91% |
| April 30, 2021 | 79.91% |
| March 31, 2021 | 79.91% |
| February 28, 2021 | 79.91% |
| January 31, 2021 | 79.91% |
| December 31, 2020 | 79.91% |
| November 30, 2020 | 79.91% |
| October 31, 2020 | 79.91% |
| September 30, 2020 | 79.91% |
| August 31, 2020 | 79.91% |
| July 31, 2020 | 79.91% |
| June 30, 2020 | 79.91% |
| May 31, 2020 | 79.91% |
| April 30, 2020 | 79.91% |
| March 31, 2020 | 79.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
13.73%
Minimum
May 2019
80.32%
Maximum
May 2022
74.98%
Average
79.91%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Biomarin Pharmaceutical Inc | 56.90% |
| Sarepta Therapeutics Inc | 64.93% |
| Dare Bioscience Inc | 99.33% |
| Zevra Therapeutics Inc | 99.27% |
| Kodiak Sciences Inc | 99.15% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -21.19 |
| Beta (5Y) | 1.916 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.4% |
| Historical Sharpe Ratio (5Y) | 0.0015 |
| Historical Sortino (5Y) | 0.0043 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.57% |